Skip to Main Content

Author Details

Kathrin Scheckenbach
Heinrich-Heine University
2002
73
23
PMIDPaper TitleJournal TitlePublished Year
36920507Recognizing cisplatin as a potential radiation recall trigger: case report and focused systematic review.Strahlenther Onkol2023
37004837Prognostic radiomic signature for head and neck cancer: Development and validation on a multi-centric MRI dataset.Radiother Oncol2023
36721989A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations.Hum Mol Genet2023
34908008DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and Survival.J Immunother2022
35795096Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells <i>in vitro</i> and <i>in vivo</i>.Mol Ther Oncolytics2022
35468475Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas.Oral Oncol2022
35464442Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies.Front Immunol2022
36442320Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.EBioMedicine2022
36411478Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection.Eur J Med Res2022
33107152Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.Head Neck2021
33852060[Droplet exposure during tracheotomy : Case analysis and consequences with respect to COVID-19 patients].HNO2021
33895463CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells.Oral Oncol2021
34901395A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cells.Mol Ther Oncolytics2021
34868059Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells.Front Immunol2021
34738049Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma.JCO Precis Oncol2021
34517930Correction to: Informed consent and informed intervention: SARSâ¿¿CoVâ¿¿2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing.Eur J Med Res2021
34530915Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.Eur J Med Res2021
34210048A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography Images.Cancers (Basel)2021
34362461Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing.Eur J Med Res2021
34311328The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysis.Oral Oncol2021
32161279Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer.Sci Rep2020
32722718Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.PLoS One2020
32281488The landscape of <i>CD28, CD80, CD86, CTLA4</i>, and <i>ICOS</i> DNA methylation in head and neck squamous cell carcinomas.Epigenetics2020
32442178Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.PLoS One2020
32384567Quality In Allergology.Laryngorhinootologie2020
30625324The Wnt-Driven Mll1 Epigenome Regulates Salivary Gland and Head and Neck Cancer.Cell Rep2019
31412811Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.BMC Cancer2019
31628024DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signature.EBioMedicine2019
29740678[Complications of anterior skull base surgery].HNO2018
30184575Endoskopische Sinuschirurgie: Checkliste hilft Problemfälle vorab zu entdecken.Laryngorhinootologie2018
29905355[Radiomics: Big Data Instead of Biopsies in the Future?]Laryngorhinootologie2018
29491055Mutational and Functional Analysis of <i>FANCB</i> as a Candidate Gene for Sporadic Head and Neck Squamous Cell Carcinomas.Anticancer Res2018
28938638Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables.Oncotarget2017
28231590Endotypes in Chronic Rhinosinusitis: Biomarkers Based on a Mechanistic Insight for Targeted Treatment?ORL J Otorhinolaryngol Relat Spec2017
28231582Radiomics in Head and Neck Cancer: Extracting Valuable Information from Data beyond Recognition.ORL J Otorhinolaryngol Relat Spec2017
28430799Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma.PLoS One2017
28099982[E-learning in ENT: Usage in University Medical Centers in Germany].Laryngorhinootologie2017
26707380Cytokine Patterns and Endotypes in Acute and Chronic Rhinosinusitis.Curr Allergy Asthma Rep2016
26307069Evaluation of Customized Prosthesis for Irregularly Formed Tracheostoma After Laryngectomy.Ann Otol Rhinol Laryngol2016
27296411Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients.Radiother Oncol2016
27092941Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies.Gene Ther2016
25474371Taking a fresh look at the skull base in otorhinolaryngology with web-based simulation: Student's Interactive Skull-Base Trainer (SISTer).JAMA Otolaryngol Head Neck Surg2015
26085575AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia.Hum Mol Genet2015
24315737RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).Oral Oncol2014
25215385[Good local control by supracricoid partial laryngectomy (SCPL)].Laryngorhinootologie2014
23883806Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge.Am J Rhinol Allergy2013
24074331Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity.Clin Exp Allergy2013
22178060Treatment of the bone marrow failure in Fanconi anemia patients with danazol.Blood Cells Mol Dis2012
22853438The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms.Clin Transl Allergy2012
22504776Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.Klin Padiatr2012
  • 1 - 50 of 73

Recommended Authors

Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 19
Moffitt Cancer Center
Career Start Year 2013
Number of shared co-authors 18
University Hospital Wurzburg
Career Start Year 2013
Number of shared co-authors 0
University of Washington
Career Start Year 2011
Number of shared co-authors 0
University of Washington
Career Start Year 2009
Number of shared co-authors 0
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 0
Niigata Prefectural Tokamachi Hospital.
Career Start Year 2007
Number of shared co-authors 0
Royal Prince Alfred Hospital
Career Start Year 2007
Number of shared co-authors 0
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 14
1 Global Smile Foundation
Career Start Year 2005
Number of shared co-authors 1
University of Tokyo
Career Start Year 2005
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 2004
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 15
Tokai University
Career Start Year 2002
Number of shared co-authors 0
The University of Texas M. D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
University of Chicago Pritzker School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai Hospital.
Career Start Year 1993
Number of shared co-authors 3
Princess Margaret Cancer Centre
Career Start Year 1992
Number of shared co-authors 8
Harvard Medical School, Brigham and Women's Hospital
Career Start Year 1992
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 6
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 4
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 1
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 3
University of California
Career Start Year 1977
Number of shared co-authors 4

Collaborators

University Hospital of Parma
Co-authored papers 9
Vrije Universiteit Amsterdam
Co-authored papers 9
Location Vrije Universiteit Amsterdam
Co-authored papers 9
Maastricht University Medical Centre
Co-authored papers 8
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Co-authored papers 8
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Co-authored papers 7
Maastricht University Medical Center (MUMC+)
Co-authored papers 4
Maastricht University
Co-authored papers 3
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 3
University of Dundee
Co-authored papers 1
Jewish General Hospital, McGill University
Co-authored papers 1
Fondazione IRCSS Istituto Nazionale dei Tumori
Co-authored papers 1
University of Western Ontario
Co-authored papers 1
University Medical Center Utrecht
Co-authored papers 1
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 1
University of British Columbia
Co-authored papers 1
University of British Columbia
Co-authored papers 1
University of Western Ontario
Co-authored papers 1
Kresge Hearing Research Institute, University of Michigan ann arbor
Co-authored papers 1
University of Western Ontario
Co-authored papers 1
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 1
Western University
Co-authored papers 1
University Children's Hospital Muenster
Co-authored papers 1
Fondazione IRCCS Istituto Nazionale dei Tumouri
Co-authored papers 1
Jewish General Hospital
Co-authored papers 1
University of Western Ontario
Co-authored papers 1
Stanford University
Co-authored papers 1
Western University
Co-authored papers 1
Co-authored papers 1
University of Western Ontario
Co-authored papers 1